Acorda Therapeutics Common Stock

Acorda Therapeutics (ACOR) currently reports a common stock of $1K as of March 2024. That compares with $24K in the prior-year period — down 95.8% year over year. Use the charts on this page to explore Acorda Therapeutics's common stock history and peer comparisons.

Acorda Therapeutics's common stock decreased from $24K to $1K — a 95.8% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Acorda Therapeutics reported $1K in common stock as of March 2024. That compares with $24K in the prior-year period — down 95.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $1K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Acorda Therapeutics, and consider following ACOR for alerts when major investors trade the stock.

Acorda Therapeutics is classified in the Healthcare sector. On common stock, it currently shows $1K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ACOR with unrelated industries.